The tamoxifen paradox —influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer

ConclusionsCompared to healthy controls, premenopausal women with breast cancer treated with tamoxifen showed an increased risk of fracture, while postmenopausal women on tamoxifen did not show any risk reduction.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research